Wordt geladen...
Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study
AIM: To evaluate the efficacy and the safety of combined 5-Fluorouracil, irinotecan, bevacizumab and sirolimus in refractory advanced colorectal carcinoma. METHODS: We initiated a regimen with at day 1 an injection (iv) of bevacizumab at 5 mg/kg, followed by 180 mg/m(2) irinotecan, followed by Leuco...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
The WJG Press and Baishideng
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2744183/ https://ncbi.nlm.nih.gov/pubmed/19750570 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.15.4278 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|